Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Corticosteroid for Ulnar Neuropathy at Elbow
NCT05567081Phase 3Completed
- Sponsor
- Tanta University
- Start
- Jun 2021
- Primary completion
- Apr 2022
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 3, randomised trial of autologous platelet-rich plasma in Ulnar neuropathy (2 arms), sponsored by Tanta University. Primary endpoints: Change in ultrasound cross sectional area of ulnar nerve at elbow at 3 months and Change in nerve conduction parameters of ulnar nerve at elbow at 3 months. Started Jun 2021; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Ulnar neuropathy
Beyond the preview
Go deeper on NCT05567081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05567081.